Abstract:Abstract Background Despite the increased morbidity of ulcerative colitis (UC) in the developing countries, available treatments remain unsatisfactory. Therefore, it is urgent to discover more effective therapeutic strategies. Pulsatilla chinensis was widely used for the treatment of inflamed intestinal diseases including UC for thousands of years in China. Anemoside B4, the most abundant triterpenoid saponin isolated from P. chinensis , exerts anti-inflammatory and antioxidant effects and may be the most active compounds, which is responsible for the therapeutic effects. However, the mechanism how anemoside B4 executes its biological functions is still elusive. Methods Here, we used the 2, 4, 6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rat model to evaluate the therapeutic effect of anemoside B4. Blood samples of colitis rats were collected for hematology analysis. The inflammation-associated factors were investigated by enzyme-linked immunosorbent assay (ELISA). Cell proliferation and apoptosis was determined with EdU cell proliferation assay and TUNEL assay. The proteins regulated by anemoside B4 were identified by label-free quantitative proteomics. The significantly down-regulated proteins were verified by Western blotting analysis. mRNA expression was analyzed by quantitative real-time RT-PCR. Results The results showed that anemoside B4 ameliorated TNBS-induced colitis symptoms, including tissue damage, inflammatory cell infiltration, and pro-inflammatory cytokine production, apoptosis and slowed proliferation in colon. Quantitative proteomic analyses discovered that 56 proteins were significantly altered by anemoside B4 in the TNBS-induced rats. These proteins mainly clustered in tricarboxylic acid (TCA) cycle and respiratory electron transport chain. Among the altered proteins, S100A9 is one of the most significantly down-regulated proteins and associated with NF-κB and MAPK signaling pathways in the pathogenesis of UC. Further experiments revealed that anemoside B4 suppressed the expression of S100A9 and its downstream genes including TLR4 and NF-κB in colon. In vitro, anemoside B4 could inhibit the NF-κB signaling pathway induced by recombinant S100A9 protein in human intestinal epithelial Caco-2 cells. Moreover, anemoside B4 inhibits neutrophils recruitment and activation in colon induced by TNBS. Conclusions Our results demonstrate that anemoside B4 prevents TNBS-induced colitis by inhibiting the NF-κB signaling pathway through deactivating S100A9, suggesting that anemoside B4 is a promising therapeutic candidate for colitis.

Oxymatrine Improves TNBS-induced Colitis in Rats by Inhibiting the Expression of NF-κB P65

Anti-inflammatory Mechanism of Oxymatrine in Dextran Sulfate Sodium-Induced Colitis of Rats.

Anti-Inflammatory Effects of Oxymatrine Through Inhibition of Nuclear Factor-Kappa B and Mitogen-Activated Protein Kinase Activation in Lipopolysaccharide-Induced Bv2 Microglia Cells

Oxymatrine Attenuates Ulcerative Colitis through Inhibiting Pyroptosis Mediated by the NLRP3 Inflammasome

Anti-Inflammatory Effects of Oxymatrine on Rheumatoid Arthritis in Rats Via Regulating the Imbalance Between Treg and Th17 Cells

Oxymatrine suppresses colorectal cancer progression by inhibiting NLRP3 inflammasome activation through mitophagy induction in vitro and in vivo

Oxymatrine Improves Intestinal Epithelial Barrier Function Involving Nf-Kappa B-Mediated Signaling Pathway In Ccl4-Induced Cirrhotic Rats

Matrine Improves 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis in Mice.

Matrine Mediates Inflammatory Response Via Gut Microbiota in TNBS-Induced Murine Colitis

Erratum to: Tanshinone IIA Ameliorates Trinitrobenzene Sulfonic Acid (TNBS)-Induced Murine Colitis

Neuroprotective Effects of Oxymatrine Against Excitotoxicity Partially Through Down-Regulation of NR2B-containing NMDA Receptors.

Oxymatrine loaded nitric oxide-releasing liposomes for the treatment of ulcerative colitis

Effects of NF-κB P65 Antisense Oligonucletide on the Expression of Cytokines and NF-κB in Colonic Intestinal Mucosa of Mice with TNBS-induced Colitis

Tetramethylpyrazine Improves Oxazolone-Induced Colitis by Inhibiting the NF-κB Pathway.

Matrine Ameliorates Spontaneously Developed Colitis in Interleukin-10-deficient Mice.

Oxymatrine alleviates NSAID-associated small bowel mucosal injury by regulating MIP-1/CCR1 signalling and gut microbiota

The ameliorative effects of astragalus and ophiopogon japonicus polysaccharides on TNBS induced colitis rats

Oxymatrine Inhibits Microglia Activation Via HSP60-TLR4 Signaling.

Oxymatrine Lightened the Inflammatory Response of LPS-induced Mastitis in Mice Through Affecting NF-κB and MAPKs Signaling Pathways.

Oxymatrine blocks the NLRP3 inflammasome pathway, partly downregulating the inflammatory responses of M1 macrophages differentiated from THP-1 monocytes

Anemoside B4 ameliorates TNBS-induced colitis through S100A9/MAPK/NF-κB signaling pathway